BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Business

  BioCision, LLC Opens Global Headquarters In San Rafael, California

  September 29, 2014

   · 

  1 min read
• FDA

  InfraReDx Receives Regulatory Approval Of TVC Imaging System In Japan

  September 29, 2014

   · 

  4 min read
• Deals

  Vitae Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering

  September 29, 2014

   · 

  1 min read
• Drug Development

  Genentech’s Investigational Combination Of Cobimetinib Plus Zelboraf (Vemurafenib) Provided Significant Benefit To People With Advanced Melanoma Over Zelboraf Alone

  September 29, 2014

   · 

  1 min read
• Deals

  Ex-Elan Corporation PLC Trio Snags Their Former Employer’s Kinase Inhibitor Program

  September 29, 2014

   · 

  1 min read
• Deals

  New U.S. Tax Rules May Lead Medtronic, Inc. To Redo Covidien plc Deal

  September 29, 2014

   · 

  1 min read
• Deals

  Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC

  September 29, 2014

   · 

  2 min read
• Drug Development

  Array BioPharma, Inc. Release: Phase 2 Trial Of Binimetinib In NRAS Melanoma Shows Promising Clinical Activity

  September 29, 2014

   · 

  4 min read
• Drug Development

  Novartis AG Drug Afinitor Is First Treatment For Advanced Pancreatic NET To Provide Overall Survival Of More Than 3.5 Years In Phase 3 Trial

  September 29, 2014

   · 

  12 min read
• FDA

  CVRx, Inc. Wins CE Mark Approval Of The Barostim Neo System™ To Treat Heart Failure

  September 29, 2014

   · 

  6 min read